START OF PAGE 1
SENATE BILL 485

J1 6lr1483
CF 6lr3417

By: Senators Carozza, Ready, West, and Jennings
Introduced and read first time: February 2, 2026
Assigned to: Finance

A BILL ENTITLED

1 AN ACT concerning

2 Public Health – Women’s Health Care Data – Report

3 FOR the purpose of requiring the Maryland Department of Health to develop and
4 implement a standard system to collect and compile annual data on the costs of
5 prenatal care, birth, postpartum care, pregnancy care, abortion services, and
6 menopausal care in the State; establishing limitations on the data and information
7 that may be collected or reported under a certain provision of this Act; and generally
8 relating to reproductive health care data.

9 BY adding to
10 Article – Health – General
11 Section 20–217 through 20–220 to be under the new part “Part V. Women’s Health
12 Data Collection and Reporting”
13 Annotated Code of Maryland
14 (2023 Replacement Volume and 2025 Supplement)

15 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
16 That the Laws of Maryland read as follows:

17 Article – Health – General

18 20–215. RESERVED.

19 20–216. RESERVED.

20 PART V. WOMEN’S HEALTH DATA COLLECTION AND REPORTING.

21 20–217.

EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW.
[Brackets] indicate matter deleted from existing law. *sb0485*
END OF PAGE 1

START OF PAGE 2
2 SENATE BILL 485

1 THE PURPOSE OF THIS PART IS TO COLLECT AND REPORT DATA REGARDING
2 THE COSTS OF PRENATAL CARE, BIRTH, POSTPARTUM CARE, PREGNANCY CARE,
3 ABORTION SERVICES, AND MENOPAUSAL CARE, TO:

4 (1) BETTER UNDERSTAND THE FINANCIAL IMPACT OF THESE
5 SERVICES ON INDIVIDUALS, PROVIDERS, AND THE STATE;

6 (2) INFORM PUBLIC POLICY DECISIONS RELATED TO MATERNAL AND
7 REPRODUCTIVE HEALTH CARE;

8 (3) EVALUATE WHETHER PUBLIC AND PRIVATE FUNDS EXPENDED
9 FOR WOMEN’S HEALTH CARE ARE USED EFFECTIVELY;

10 (4) PERFORM COST ANALYSES TO IDENTIFY GAPS OR EMERGING
11 NEEDS RELATED TO WOMEN’S HEALTH CARE; AND

12 (5) PROMOTE TRANSPARENCY AND ACCOUNTABILITY IN HEALTH
13 CARE SPENDING WHILE SAFEGUARDING THE PRIVACY AND DIGNITY OF ALL
14 INDIVIDUALS.

15 20–218.

16 (A) THE DEPARTMENT SHALL COLLECT AND COMPILE DATA ANNUALLY
17 REGARDING THE COSTS OF:

18 (1) DELIVERY, INCLUDING:

19 (I) STANDARD DELIVERY COSTS;

20 (II) COSTS OF COMPLICATIONS, INCLUDING EMERGENCY
21 INTERVENTIONS AND EXTENDED HOSPITAL STAYS; AND

22 (III) NEONATAL CARE, IF APPLICABLE;

23 (2) POSTPARTUM CARE, INCLUDING:

24 (I) FOLLOW–UP MEDICAL VISITS; AND

25 (II) COSTS ASSOCIATED WITH ADDRESSING POSTPARTUM
26 MENTAL HEALTH CONDITIONS, INCLUDING POSTPARTUM DEPRESSION;

27 (3) PREGNANCY CARE, INCLUDING:
END OF PAGE 2

START OF PAGE 3
SENATE BILL 485 3

1 (I) ROUTINE OBSTETRIC AND GYNECOLOGICAL VISITS;

2 (II) PRENATAL VITAMINS AND SUPPLEMENTS;

3 (III) DIAGNOSTIC AND MONITORING SERVICES, INCLUDING
4 ULTRASOUNDS AND GENETIC TESTING; AND

5 (IV) PERINATAL MENTAL HEALTH CONDITIONS, INCLUDING
6 PERINATAL DEPRESSION;

7 (4) SUBJECT TO SUBSECTION (B) OF THIS SECTION, ABORTION,
8 INCLUDING:

9 (I) PROCEDURAL COSTS;

10 (II) COSTS ASSOCIATED WITH COMPLICATIONS OR FOLLOW–UP
11 CARE;

12 (III) PRESCRIPTION COSTS FOR ABORTION PILLS, INCLUDING
13 COSTS ASSOCIATED WITH ABORTION PILL REVERSALS;

14 (IV) COSTS OF ABORTION CARE TRAINING PROGRAMS UNDER §
15 13–4704 OF THIS ARTICLE; AND

16 (V) POST–ABORTIVE MENTAL HEALTH SYMPTOMS, INCLUDING
17 ANXIETY, DEPRESSION, OR TRAUMA–RELATED INDICATORS; AND

18 (5) MENOPAUSE–RELATED HEALTH CARE, INCLUDING:

19 (I) UTILIZATION AND ASSOCIATED COSTS OF HORMONAL AND
20 NONHORMONAL THERAPIES;

21 (II) AVAILABILITY AND ACCESSIBILITY OF EDUCATIONAL AND
22 COMMUNICATIONS RESOURCES FOR PATIENTS AND HEALTH CARE PROVIDERS; AND

23 (III) MENTAL HEALTH CONDITIONS RELATED TO
24 PERIMENOPAUSE, MENOPAUSE, AND POSTMENOPAUSE, INCLUDING DIAGNOSIS,
25 TREATMENT, AND LONG–TERM MANAGEMENT.

26 (B) DATA COLLECTED UNDER SUBSECTION (A)(4) OF THIS SECTION:

27 (1) SHALL INCLUDE ONLY AGGREGATED BUDGET AND EXPENDITURE
28 DATA; AND
END OF PAGE 3

START OF PAGE 4
4 SENATE BILL 485

1 (2) MAY NOT INCLUDE PROCEDURE–LEVEL DETAILS OR ANY OTHER
2 INFORMATION PROHIBITED FROM DISCLOSURE UNDER STATE LAW.

3 (C) MARYLAND MEDICAL ASSISTANCE PROGRAM FUNDS USED FOR
4 CHEMICAL OR SURGICAL ABORTION PROCEDURES SHALL BE TRACKED TO INCLUDE:

5 (1) THE TOTAL EXPENDITURE ALLOCATED FOR CHEMICAL
6 ABORTIONS, INCLUDING ASSOCIATED PRESCRIPTION COSTS; AND

7 (2) THE TOTAL EXPENDITURE FOR SURGICAL ABORTIONS,
8 INCLUDING PRE– AND POSTOPERATIVE CARE.

9 (D) (1) THE DEPARTMENT SHALL DEVELOP AND IMPLEMENT A
10 STANDARDIZED REPORTING SYSTEM, INCLUDING FORMS OR WORKSHEETS WITH
11 INSTRUCTIONS, FOR THE COLLECTION OF REVENUES, CHARGES, PRICES, AND
12 UTILIZATION DATA RELATED TO WOMEN’S HEALTH CARE SERVICES FOR BUDGETARY
13 ANALYSIS AND EXPENDITURE MONITORING.

14 (2) UNIFORM REPORTING REQUIREMENTS UNDER THIS SUBSECTION
15 SHALL ALLOW THE DEPARTMENT TO IDENTIFY STATEWIDE AND REGIONAL TRENDS
16 IN THE COST, PRICE, AVAILABILITY, AND UTILIZATION OF WOMEN’S MEDICAL,
17 SURGICAL, REPRODUCTIVE, DIAGNOSTIC, PRENATAL, POSTPARTUM, MENOPAUSAL,
18 AND OTHER HEALTH CARE SERVICES.

19 (E) THE FOLLOWING ENTITIES SHALL USE THE REPORTING SYSTEM
20 DEVELOPED UNDER SUBSECTION (D) OF THIS SECTION TO REPORT APPLICABLE
21 DATA DESCRIBED UNDER SUBSECTION (A) OF THIS SECTION TO THE DEPARTMENT:

22 (1) EACH HOSPITAL LICENSED UNDER TITLE 19, SUBTITLE 3 OF THIS
23 ARTICLE;

24 (2) EACH HEALTH CARE PROVIDER LICENSED UNDER THE HEALTH
25 OCCUPATIONS ARTICLE; AND

26 (3) ANY OTHER ENTITY THAT PROVIDES A SERVICE DESCRIBED
27 UNDER SUBSECTION (A) OF THIS SECTION.

28 20–219.

29 (A) THE DEPARTMENT IS NOT REQUIRED TO COLLECT OR REPORT DATA
30 THAT WOULD VIOLATE FEDERAL OR STATE PRIVACY LAWS, INCLUDING §§ 4–301
31 THROUGH 4–309 OF THIS ARTICLE.
END OF PAGE 4

START OF PAGE 5
SENATE BILL 485 5

1 (B) AN ENTITY LISTED UNDER § 20–218(E) OF THIS SUBTITLE SHALL:

2 (1) COMPLY WITH THE DEPARTMENT’S DATA SUBMISSION
3 REQUIREMENTS; AND

4 (2) ANONYMIZE AND DE–IDENTIFY PATIENT DATA AS NECESSARY TO
5 COMPLY WITH APPLICABLE FEDERAL AND STATE PRIVACY LAWS.

6 (C) (1) DATA COLLECTED UNDER § 20–218(A) OF THIS SUBTITLE SHALL
7 BE LIMITED TO THE INFORMATION NECESSARY TO ASSESS THE COSTS OF SERVICES
8 FOR EACH CATEGORY OF CARE DESCRIBED IN § 20–218(A) OF THIS SUBTITLE.

9 (2) THE DEPARTMENT OR ANY ENTITY LISTED UNDER § 20–218(E) OF
10 THIS SUBTITLE MAY NOT COLLECT OR REPORT PERSONAL HEALTH INFORMATION
11 OR ANY OTHER IDENTIFIABLE PATIENT DATA IN COMPLYING WITH § 20–218 OF THIS
12 SUBTITLE.

13 (D) NOTWITHSTANDING § 20–218 OF THIS SUBTITLE, THIS SUBTITLE MAY
14 NOT BE CONSTRUED TO AUTHORIZE OR REQUIRE THE COLLECTION OR DISCLOSURE
15 OF INDIVIDUALLY IDENTIFIABLE PATIENT INFORMATION OR ANY OTHER DATA THAT
16 MAY COMPROMISE PATIENT PRIVACY OR CONFIDENTIALITY.

17 20–220.

18 (A) ON OR BEFORE DECEMBER 1 EACH YEAR, BEGINNING IN 2026, THE
19 DEPARTMENT SHALL SUBMIT A COMPREHENSIVE REPORT TO THE GENERAL
20 ASSEMBLY, IN ACCORDANCE WITH § 2–1257 OF THE STATE GOVERNMENT ARTICLE,
21 AND MAKE THE REPORT PUBLICLY AVAILABLE ON ITS WEBSITE.

22 (B) THE REPORT SHALL INCLUDE THE FOLLOWING INFORMATION FOR THE
23 IMMEDIATELY PRECEDING FISCAL YEAR:

24 (1) AGGREGATED COST DATA FOR EACH CATEGORY OF CARE
25 DESCRIBED UNDER § 20–218(A) OF THIS SUBTITLE;

26 (2) COMPARATIVE DATA BY REGION WITHIN THE STATE;

27 (3) ANALYSIS OF TRENDS IN THE COSTS OF EACH CATEGORY OF CARE
28 OVER TIME; AND

29 (4) RECOMMENDATIONS, IF ANY, FOR IMPROVING COST EFFICIENCY.
END OF PAGE 5

START OF PAGE 6
6 SENATE BILL 485

1 (C) THE REPORT:

2 (1) MAY NOT INCLUDE ANY PERSONALLY IDENTIFIABLE
3 INFORMATION; AND

4 (2) SHALL COMPLY WITH ALL APPLICABLE FEDERAL AND STATE
5 PRIVACY LAWS, INCLUDING THE FEDERAL HEALTH INSURANCE PORTABILITY AND
6 ACCOUNTABILITY ACT.

7 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect June
8 1, 2026.
END OF PAGE 6